Skip to content
Every compound links to batch-tested stock at Nordapep, with a Certificate of Analysis per batch.
peptide.wiki

AOD-9604

AOD-9604 is a 16-amino-acid peptide based on the C-terminal region of human growth hormone, with an added N-terminal tyrosine. It was designed to isolate the fat-metabolism effects seen in animal work from growth hormone's wider actions, but human obesity trials did not show a meaningful benefit over placebo.

Not approvedMetabolic & incretin researchModified fragment of the growth hormone tail2/52/5

At a glance

2/52/5
Class
Growth hormone fragment
Receptor targets
Not fully defined (proposed β3-adrenergic-linked lipolysis in rodents)
Length
16 amino acids (modified fragment, with N-terminal tyrosine)
Molecular mass
≈ 1.82 kDa
Origin
Synthetic, derived from human growth hormone
Research area
Metabolic & incretin research
Also known as
Tyr-hGH fragment 177-191, Anti-Obesity Drug 9604

What AOD-9604 is

In the 1990s, researchers found that a short C-terminal piece of growth hormone reproduced anti-lipogenic activity in rodent fat tissue. AOD-9604 was developed from that fragment, with a tyrosine added for stability, as a candidate anti-obesity compound.

The compound reached phase 2b human trials, where it failed to beat placebo on weight loss, and the obesity programme was discontinued. It has since been classed as a food ingredient in some jurisdictions, and is prohibited in sport. It is often confused with the unmodified fragment 176-191, which has even less human data.

What the research literature studies

  • Lipolysis and lipogenesis in adipose tissue models
  • Comparisons with intact growth hormone in rodents
  • Structure-activity work on growth hormone C-terminal fragments

Evidence rating: 2/5

Mostly animal and in vitro. Rodent studies plus human trials that did not show clear benefit. Never approved as a medicine. See our methodology for how levels are assigned.

  • Human obesity trials did not show a clear effect, so animal results should not be extrapolated.
  • Often sold interchangeably with unmodified fragment 176-191, which is a different molecule.

Regulatory status

AOD-9604 is not an approved medicine, and its regulatory classification varies between countries. It is prohibited under anti-doping rules. Research-grade material must not be used in people or animals.

Reviewed November 2026.

AOD-9604 at Nordapep: sizes and price per mg

Every size, its price and the cost per milligram, so you can choose the best-value vial for your protocol.

Not currently listed at Nordapep.

Compare AOD-9604

AOD-9604 FAQ

Is AOD-9604 the same as fragment 176-191?

Not exactly. AOD-9604 is a modified version, with an added tyrosine and a slightly different span, so the two should not be treated as interchangeable.

Does AOD-9604 act like growth hormone?

It was designed not to. The idea was to keep fat-metabolism activity without growth hormone receptor effects, although human trials did not confirm a benefit.

Where can I buy AOD-9604 for research?

Nordapep does not currently list AOD-9604. You can ask Nordapep about availability, or compare related compounds that are in stock.

Is AOD-9604 approved?

AOD-9604 is not an approved medicine, and its regulatory classification varies between countries. It is prohibited under anti-doping rules. Research-grade material must not be used in people or animals.

Key terms for AOD-9604

Cite this page

peptide.wiki. (2026). AOD-9604: research peptide profile. peptide.wiki. https://www.peptide.wiki/peptides/aod-9604
Free to cite and link. Last reviewed November 2026.
For laboratory research only. Nothing on peptide.wiki is medical advice. The compounds described are not for human or veterinary use, and research-grade material is not a medicine.

Related compounds